Skip to main content
Back
SHPHF logo

Sihuan Pharmaceutical Holdings Group Ltd.

Data quality: 100%
Overbought
SHPHF
OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.19
▲ $0.02 (9.68%)
Mkt Cap: 1.71B
Day Range
$0.19 $0.19
52-Week Range
$0.05 $0.21
Volume
300
50D / 200D Avg
$0.18 / $0.12
Prev Close
$0.19

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -7.9 0.4
P/B 0.4 2.9
ROE % -4.9 3.8
Net Margin % -11.4 3.9
Rev Growth 5Y % -6.3 10.0
D/E 0.2 0.2

Key Takeaways

Revenue declined -6.28% annually over 5 years
Debt/Equity of 0.22 — conservative balance sheet
Generating 57.51M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.46%
Capital efficient — spends only 9.80% of revenue on capex

Growth

Revenue Growth (5Y)
-6.28%
Revenue (1Y)2.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-4.92%
ROIC-1.94%
Net Margin-11.40%
Op. Margin-7.27%

Safety

Debt / Equity
0.22
Current Ratio1.73
Interest Coverage-0.50

Valuation

P/E Ratio
-7.87
P/B Ratio0.39
EV/EBITDAN/A
Dividend Yield0.05%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.18% Revenue Growth (3Y) -6.64%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -6.28% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.90B Net Income (TTM) -216.66M
ROE -4.92% ROA -2.06%
Gross Margin 65.32% Operating Margin -7.27%
Net Margin -11.40% Free Cash Flow (TTM) 57.51M
ROIC -1.94% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.22 Current Ratio 1.73
Interest Coverage -0.50 Dividend Yield 0.05%
Valuation
P/E Ratio -7.87 P/B Ratio 0.39
P/S Ratio 0.90 PEG Ratio -0.05
EV/EBITDA N/A Dividend Yield 0.05%
Market Cap 1.71B Enterprise Value -942.07M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 1.90B 1.86B 2.18B 3.04B 2.46B
Net Income -216.66M -54.02M -1.91B 416.51M 473.38M
EPS (Diluted) -0.02 -0.01 -0.21 0.04 0.05
Gross Profit 1.24B 1.30B 1.49B 2.43B 1.91B
Operating Income -138.13M 161.70M -1.83B 771.95M 787.13M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 10.53B 11.54B 12.14B 14.50B 13.04B
Total Liabilities 5.58B 6.40B 6.50B 5.35B 3.10B
Shareholders' Equity 4.37B 4.43B 4.74B 8.28B 9.19B
Total Debt 974.01M 1.26B 1.29B 1.08B 755.05M
Cash & Equivalents 3.62B 3.89B 3.83B 5.68B 4.60B
Current Assets 5.72B 6.20B 6.55B 7.74B 6.40B
Current Liabilities 3.31B 4.11B 2.53B 2.50B 2.44B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#204 of 820
56

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026